Luján Jorge A, Rugeles Maria T, Taborda Natalia A
Grupo Inmunovirologia, Facultad de Medicina. Universidad de Antioquia, Medellin, Colombia.
Grupo de Investigaciones Biomédicas, Facultad de Ciencias de la Salud, Corporación Universitaria Remington, Medellín, Colombia.
Curr HIV Res. 2019;17(1):13-25. doi: 10.2174/1570162X17666190311114808.
During HIV infection, massive destruction of CD4+ T cells ensues, preferentially depleting the Th17 subset at the gut-associated lymphoid tissue (GALT), leading to a loss of mucosal integrity and an increase in cell permeability. This process favors microbial translocation between the intestinal lumen and the circulatory system, contributing to persistent immune activation and chronic inflammation characteristic of HIV infection. Thus, the gut microbiota plays an integral role in maintaining the structure and function of the mucosal barrier, a critical factor for immune homeostasis. However, in the context of HIV infection, changes in the gut microbiota have been reported and have been linked to disease progression. Here, we review evidence for the role of the gut microbiota in intestinal homeostasis, its contribution to HIV pathogenesis, as well as its use in the development of therapeutic strategies.
在HIV感染期间,CD4+ T细胞会大量被破坏,优先消耗肠道相关淋巴组织(GALT)中的Th17亚群,导致黏膜完整性丧失和细胞通透性增加。这一过程有利于微生物在肠腔和循环系统之间易位,促使HIV感染所特有的持续免疫激活和慢性炎症。因此,肠道微生物群在维持黏膜屏障的结构和功能方面起着不可或缺的作用,而黏膜屏障是免疫稳态的关键因素。然而,在HIV感染的背景下,已有报道称肠道微生物群发生了变化,且与疾病进展有关。在此,我们综述了肠道微生物群在肠道稳态中的作用、其对HIV发病机制的影响以及在治疗策略开发中的应用的相关证据。